BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2425957)

  • 1. Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells.
    Kaysen J; Spriggs D; Kufe D
    Cancer Res; 1986 Sep; 46(9):4534-8. PubMed ID: 2425957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).
    Beumer JH; Parise RA; Newman EM; Doroshow JH; Synold TW; Lenz HJ; Egorin MJ
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):363-8. PubMed ID: 17899082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells.
    Major PP; Egan E; Herrick D; Kufe DW
    Cancer Res; 1982 Aug; 42(8):3005-9. PubMed ID: 6212116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of methotrexate on incorporation and excision of 5-fluorouracil residues in human breast carcinoma DNA.
    Herrick DJ; Major PP; Kufe DW
    Cancer Res; 1982 Dec; 42(12):5015-7. PubMed ID: 7139606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.
    Vandamme B; Liebaers I; Hens L; Bernheim JL; Roobol C
    Hum Genet; 1988 Aug; 79(4):341-6. PubMed ID: 2970425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Greer SB
    Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and mechanism of action of 5-fluorodeoxycytidine.
    Newman EM; Santi DV
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6419-23. PubMed ID: 6959127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice.
    Beumer JH; Eiseman JL; Parise RA; Joseph E; Holleran JL; Covey JM; Egorin MJ
    Clin Cancer Res; 2006 Dec; 12(24):7483-91. PubMed ID: 17138702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 5-[
    Yu HM; Chiu CH; Chen WT; Wu CH; Lin PY; Huang YY; Chen JH; Tzen KY; Shiue CY; Lin WJ
    Appl Radiat Isot; 2019 Jun; 148():152-159. PubMed ID: 30959352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humans.
    Holleran JL; Beumer JH; McCormick DL; Johnson WD; Newman EM; Doroshow JH; Kummar S; Covey JM; Davis M; Eiseman JL
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):803-11. PubMed ID: 26321472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.
    Cory JG; Breland JC; Carter GL
    Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma.
    Holleran JL; Eiseman JL; Parise RA; Kummar S; Beumer JH
    J Pharm Biomed Anal; 2016 Sep; 129():359-366. PubMed ID: 27454087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of deamination-related cytotoxicity of 5-methyl-2'-deoxycytidine by tetrahydrouridine in human leukemia cells.
    Jekunen A; Vilpo JA
    J Natl Cancer Inst; 1984 Nov; 73(5):1087-91. PubMed ID: 6593484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in combination.
    Guo D; Myrdal PB; Karlage KL; O'Connell SP; Wissinger TJ; Tabibi SE; Yalkowsky SH
    AAPS PharmSciTech; 2010 Mar; 11(1):247-52. PubMed ID: 20151336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.